mRNA Vaccine Shows Promising Potential to Prevent Melanoma Recurrence in Flagstaff and Beyond

An experimental mRNA vaccine allowed people with high-risk melanoma to live longer, cancer-free, in a large, closely watched trial, pharmaceutical companies Moderna and Merck announced Wednesday.